{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:02:29Z","timestamp":1792839749461,"version":"4.5.0"},"reference-count":33,"publisher":"Massachusetts Medical Society","issue":"6","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN2662040074C"],"award-info":[{"award-number":["HHSN2662040074C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2021,2,11]]},"DOI":"10.1056\/nejmoa2023345","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T17:20:14Z","timestamp":1612977614000},"page":"541-549","source":"Crossref","is-referenced-by-count":179,"title":["Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection"],"prefix":"10.1056","volume":"384","author":[{"given":"Kimberly","family":"Page","sequence":"first","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Melia","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca T.","family":"Veenhuis","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Winter","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3097-0289","authenticated-orcid":false,"given":"Kimberly E.","family":"Rousseau","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Massaccesi","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William O.","family":"Osburn","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Forman","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Thomas","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Thornton","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Wagner","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ventzislav","family":"Vassilev","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Lin","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula J.","family":"Lum","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda C.","family":"Giudice","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Stein","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Asher","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soju","family":"Chang","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gorman","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc G.","family":"Ghany","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Jake","family":"Liang","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Wierzbicki","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Scarselli","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Nicosia","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Folgori","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Capone","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Cox","sequence":"additional","affiliation":[{"name":"From the University of New Mexico, Albuquerque (K.P., E.T., K.T., K.W.); Johns Hopkins University, Baltimore (M.T.M., R.T.V., M.W., K.E.R., G.M., W.O.O., M.F., A.L.C.), the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (S. Chang, R.G.), and the Emmes Company (M.R.W.), Rockville, and the Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda (M.G.G., T.J.L.) \u2014 all in..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.12998\/wjcc.v6.i13.589","article-title":"Update on global epidemiology of viral hepatitis and preventive strategies.","volume":"6","author":"Jefferies M","year":"2018","unstructured":"Jefferies M, Rauff B, Rashid H, Lam T, Rafiq S. Update on global epidemiology of viral hepatitis and preventive strategies. World J Clin Cases 2018;6:589-599.30430114","journal-title":"World J Clin Cases"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2055-6640(20)30329-0","article-title":"The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries.","volume":"3","author":"Hill AM","year":"2017","unstructured":"Hill AM, Nath S, Simmons B. The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries. J Virus Erad 2017;3:117-123.28758018","journal-title":"J Virus Erad"},{"key":"e_1_3_4_4_2","unstructured":"World Health Organization. Global hepatitis report 2017 (https:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en\/)."},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.15585\/mmwr.mm6914a2","article-title":"Vital signs: newly reported acute and chronic hepatitis C cases \u2014 United States, 2009\u20132018.","volume":"69","author":"Ryerson AB","year":"2020","unstructured":"Ryerson AB, Schillie S, Barker LK, Kupronis BA, Wester C. Vital signs: newly reported acute and chronic hepatitis C cases \u2014 United States, 2009\u20132018. MMWR Morb Mortal Wkly Rep 2020;69:399-404.32271725","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jvh.12248","article-title":"The present and future disease burden of hepatitis C virus (HCV) infection with today\u2019s treatment paradigm.","volume":"21","author":"Razavi H","year":"2014","unstructured":"Razavi H, Waked I, Sarrazin C, et al. The present and future disease burden of hepatitis C virus (HCV) infection with today\u2019s treatment paradigm. J Viral Hepat 2014;21:Suppl 1:34-59.24713005","journal-title":"J Viral Hepat"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cmi.2020.01.014","article-title":"Elimination of hepatitis C in Europe: can WHO targets be achieved?","volume":"26","author":"Mati\u010di\u010d M","year":"2020","unstructured":"Mati\u010di\u010d M, Lombardi A, Mondelli MU, Colombo M. Elimination of hepatitis C in Europe: can WHO targets be achieved? Clin Microbiol Infect 2020;26:818-823.31978546","journal-title":"Clin Microbiol Infect"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virusres.2018.02.016","article-title":"Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: considerations for scientists and funding agencies.","volume":"248","author":"Bartenschlager R","year":"2018","unstructured":"Bartenschlager R, Baumert TF, Bukh J, et al. Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: considerations for scientists and funding agencies. Virus Res 2018;248:53-62.29477639","journal-title":"Virus Res"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/hep.31182","article-title":"Hepatitis C vaccine: 10 good reasons for continuing.","volume":"71","author":"Roingeard P","year":"2020","unstructured":"Roingeard P, Beaumont E. Hepatitis C vaccine: 10 good reasons for continuing. Hepatology 2020;71:1845-1850.32060946","journal-title":"Hepatology"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"261ra153","DOI":"10.1126\/scitranslmed.3009185","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.","volume":"6","author":"Swadling L","year":"2014","unstructured":"Swadling L, Capone S, Antrobus RD, et al. A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory. Sci Transl Med 2014;6:261ra153-261ra153.25378645","journal-title":"Sci Transl Med"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.3389\/fimmu.2018.03175","article-title":"A novel vaccine strategy employing serologically different chimpanzee adenoviral vectors for the prevention of HIV-1 and HCV coinfection.","volume":"9","author":"Hartnell F","year":"2019","unstructured":"Hartnell F, Brown A, Capone S, et al. A novel vaccine strategy employing serologically different chimpanzee adenoviral vectors for the prevention of HIV-1 and HCV coinfection. Front Immunol 2019;9:3175-3175.30713538","journal-title":"Front Immunol"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.26639","article-title":"The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection.","volume":"59","author":"Grebely J","year":"2014","unstructured":"Grebely J, Page K, Sacks-Davis R, et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology 2014;59:109-120.23908124","journal-title":"Hepatology"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.","volume":"461","author":"Thomas DL","year":"2009","unstructured":"Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009;461:798-801.19759533","journal-title":"Nature"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.","volume":"138","author":"Osburn WO","year":"2010","unstructured":"Osburn WO, Fisher BE, Dowd KA, et al. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology 2010;138:315-324.19782080","journal-title":"Gastroenterology"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.","volume":"200","author":"Page K","year":"2009","unstructured":"Page K, Hahn JA, Evans J, et al. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis 2009;200:1216-1226.19764883","journal-title":"J Infect Dis"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1537-2995.2005.04390.x","article-title":"Dynamics of viremia in early hepatitis C virus infection.","volume":"45","author":"Glynn SA","year":"2005","unstructured":"Glynn SA, Wright DJ, Kleinman SH, et al. Dynamics of viremia in early hepatitis C virus infection. Transfusion 2005;45:994-1002.15934999","journal-title":"Transfusion"},{"issue":"4","key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"e0122232","DOI":"10.1371\/journal.pone.0122232","article-title":"Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study.","volume":"10","author":"Hajarizadeh B","year":"2015","unstructured":"Hajarizadeh B, Grady B, Page K, et al. Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study. PLoS One 2015;10(4):e0122232-e0122232.25837807","journal-title":"PLoS One"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","unstructured":"Larrey D Ripault MP. Illegal and recreational compounds: hepatotoxicity of psychotropic drugs and drugs of abuse. In: Kaplowitz N DeLeve LD eds. Drug-induced liver disease. 3rd ed. Philadelphia: Elsevier 2013:456-457.","DOI":"10.1016\/B978-0-12-387817-5.00025-X"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2105\/AJPH.2017.304201","article-title":"Opioids, hepatitis C virus infection, and the missing vaccine.","volume":"108","author":"Page K","year":"2018","unstructured":"Page K, Cox A, Lum PJ. Opioids, hepatitis C virus infection, and the missing vaccine. Am J Public Health 2018;108:156-157.29320280","journal-title":"Am J Public Health"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1473-3099(07)70237-2","article-title":"Vaccine immunogenicity in injecting drug users: a systematic review.","volume":"7","author":"Baral S","year":"2007","unstructured":"Baral S, Sherman SG, Millson P, Beyrer C. Vaccine immunogenicity in injecting drug users: a systematic review. Lancet Infect Dis 2007;7:667-674.17897609","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/08892220050042846","article-title":"A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection.","volume":"16","author":"McElrath MJ","year":"2000","unstructured":"McElrath MJ, Corey L, Montefiori D, et al. A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Res Hum Retroviruses 2000;16:907-919.10875616","journal-title":"AIDS Res Hum Retroviruses"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/cid\/cix768","article-title":"The effect of female sex on hepatitis C incidence among people who inject drugs: results from the International Multicohort InC3 Collaborative.","volume":"66","author":"Esmaeili A","year":"2018","unstructured":"Esmaeili A, Mirzazadeh A, Morris MD, et al. The effect of female sex on hepatitis C incidence among people who inject drugs: results from the International Multicohort InC3 Collaborative. Clin Infect Dis 2018;66:20-28.29020200","journal-title":"Clin Infect Dis"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-cellbio-100616-060718","article-title":"Sex and gender differences in the outcomes of vaccination over the life course.","volume":"33","author":"Flanagan KL","year":"2017","unstructured":"Flanagan KL, Fink AL, Plebanski M, Klein SL. Sex and gender differences in the outcomes of vaccination over the life course. Annu Rev Cell Dev Biol 2017;33:577-599.28992436","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"4","key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"e18526","DOI":"10.1371\/journal.pone.0018526","article-title":"Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5\/HIV-1 vaccine candidate in humans.","volume":"6","author":"Pine SO","year":"2011","unstructured":"Pine SO, Kublin JG, Hammer SM, et al. Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5\/HIV-1 vaccine candidate in humans. PLoS One 2011;6(4):e18526-e18526.21533229","journal-title":"PLoS One"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI60202","article-title":"Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine.","volume":"122","author":"Frahm N","year":"2012","unstructured":"Frahm N, DeCamp AC, Friedrich DP, et al. Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. J Clin Invest 2012;122:359-367.22201684","journal-title":"J Clin Invest"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/nm.3408","article-title":"Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection.","volume":"19","author":"Park SH","year":"2013","unstructured":"Park SH, Veerapu NS, Shin EC, et al. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med 2013;19:1638-1642.24270546","journal-title":"Nat Med"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.tim.2018.04.002","article-title":"Can broadly neutralizing monoclonal antibodies lead to a hepatitis C virus vaccine?","volume":"26","author":"Kinchen VJ","year":"2018","unstructured":"Kinchen VJ, Cox AL, Bailey JR. Can broadly neutralizing monoclonal antibodies lead to a hepatitis C virus vaccine? Trends Microbiol 2018;26:854-864.29703495","journal-title":"Trends Microbiol"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1073\/pnas.91.4.1294","article-title":"Vaccination of chimpanzees against infection by the hepatitis C virus.","volume":"91","author":"Choo Q-L","year":"1994","unstructured":"Choo Q-L, Kuo G, Ralston R, et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A 1994;91:1294-1298.7509068","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S1074-7613(01)00245-X","article-title":"The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes.","volume":"15","author":"Erickson AL","year":"2001","unstructured":"Erickson AL, Kimura Y, Igarashi S, et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 2001;15:883-895.11754811","journal-title":"Immunity"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.20050121","article-title":"Cellular immune selection with hepatitis C virus persistence in humans.","volume":"201","author":"Cox AL","year":"2005","unstructured":"Cox AL, Mosbruger T, Mao Q, et al. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 2005;201:1741-1752.15939790","journal-title":"J Exp Med"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/eji.201444686","article-title":"Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes.","volume":"45","author":"Kelly C","year":"2015","unstructured":"Kelly C, Swadling L, Brown A, et al. Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes. Eur J Immunol 2015;45:309-316.25263407","journal-title":"Eur J Immunol"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10900-007-9083-3","article-title":"Limited uptake of hepatitis C treatment among injection drug users.","volume":"33","author":"Mehta SH","year":"2008","unstructured":"Mehta SH, Genberg BL, Astemborski J, et al. Limited uptake of hepatitis C treatment among injection drug users. J Community Health 2008;33:126-133.18165889","journal-title":"J Community Health"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2019.02.008","article-title":"Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: low number treated.","volume":"198","author":"Morris MD","year":"2019","unstructured":"Morris MD, Mirzazadeh A, Evans JL, et al. Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: low number treated. Drug Alcohol Depend 2019;198:133-135.30921649","journal-title":"Drug Alcohol Depend"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3109\/10826084.2016.1161054","article-title":"Clinicians\u2019 views of hepatitis C virus treatment candidacy with direct-acting antiviral regimens for people who inject drugs.","volume":"51","author":"Asher AK","year":"2016","unstructured":"Asher AK, Portillo CJ, Cooper BA, Dawson-Rose C, Vlahov D, Page KA. Clinicians\u2019 views of hepatitis C virus treatment candidacy with direct-acting antiviral regimens for people who inject drugs. Subst Use Misuse 2016;51:1218-1223.27219274","journal-title":"Subst Use Misuse"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2023345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T20:24:58Z","timestamp":1711484698000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2023345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,2,11]]}},"alternative-id":["10.1056\/NEJMoa2023345"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2023345","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]}}}